Authors/Disclosures
|
Felipe Von Glehn Silva, MD, PhD, MSc, FAAN
(University of Brasilia – School of Medicine)
|
Dr. Von Glehn Silva has nothing to disclose. |
|
Claire Henchcliffe, MD, PhD, FAAN
(University of California, Irvine)
|
Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AskBio. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tolmar. Dr. Henchcliffe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Savanna. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Meira GTx. Dr. Henchcliffe has or had stock in Axent Biosciences Inc. The institution of Dr. Henchcliffe has received research support from Weston Brain Institute. The institution of Dr. Henchcliffe has received research support from Blue Rock Therapeutics. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Parkinson Study Group. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker/Course director with AAN. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Cleveland Clinic Foundation. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Vertex. Dr. Henchcliffe has received personal compensation in the range of $500-$4,999 for serving as a Speaker with ESGCT. |
|
Sven O. Jarius, MD
(University of Heidelberg)
|
Dr. Jarius has nothing to disclose. |
|
|
No disclosure on file |
|
Carlos Otavio Brandao, MD, PhD
(Neurolife)
|
No disclosure on file |
|
|
No disclosure on file |
|
Alfredo Damasceno, MD
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Klaus-Peter Wandinger, MD
(Charite, Neurology Dept)
|
No disclosure on file |
|
Benito P. Damasceno, MD, PhD
(Neurology Department, Medical School, State University of Campinas (UNICAMP))
|
No disclosure on file |
|
Brigitte Wildemann, MD
(University Hospital Heidelberg, Department of Neurology)
|
The institution of Dr. Wildemann has received research support from Roche. The institution of Dr. Wildemann has received research support from Novartis. The institution of Dr. Wildemann has received research support from Argenx. Dr. Wildemann has received personal compensation in the range of $500-$4,999 for serving as a Conference participant with Neuraxpharm. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Speaker with Roche. Dr. Wildemann has received personal compensation in the range of $0-$499 for serving as a Soeaker with Instand. |
|
|
No disclosure on file |